The secondary outcomes reveal an interesting trend in the glibenclamide group, where the proportion of patients showing improved functionality increased over time.
← all excerpts
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial.
1
—
—